Tim-3 finds its place in the cancer immunotherapy landscape.
J Immunother Cancer. 2020 Jun;8(1):e000911. doi: 10.1136/jitc-2020-000911.
J Immunother Cancer. 2020.
PMID: 32601081
Free PMC article.
Review.